Low-dose dopamine in the intensive care unit.

Area of Science:

• Nephrology
• Critical Care Medicine
• Pharmacology

Background:

• Low-dose dopamine has been a standard treatment for intensive care unit (ICU) renal failure for decades.
• Studying renal failure in the ICU is challenging due to complex causes and multiple organ dysfunction.

Purpose of the Study:

• To evaluate the efficacy and safety of low-dose dopamine in ICU patients with renal failure.
• To determine if low-dose dopamine improves renal function, mortality, or need for dialysis.

Main Methods:

• Review of recent meta-analyses and a large randomized controlled trial.
• Analysis of dopamine's effects on renal function, mortality, creatinine clearance, and dialysis incidence.
• Assessment of dopamine's adverse effects on various organ systems.

Main Results:

• Recent evidence indicates low-dose dopamine provides no significant benefit for renal function in ICU patients.
• Dopamine does not improve mortality, creatinine clearance, or reduce the incidence of dialysis.
• Growing evidence suggests adverse effects on immune, endocrine, and respiratory systems, potentially increasing sepsis mortality.

Conclusions:

• The use of low-dose dopamine for renal failure in the ICU should be discontinued.
• Further research into alternative therapies for ICU-acquired renal failure is urgently needed.